- Home
- CORT vs ACHC Comparison
CORT vs ACHC Comparison
Compare CORT & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CORT
- ACHC
- Stock Information
- Founded
- CORT 1998
- ACHC 2005
- Country
- CORT United States
- ACHC United States
- Employees
- CORT N/A
- ACHC N/A
- Industry
- CORT Biotechnology: Pharmaceutical Preparations
- ACHC Medical Specialities
- Sector
- CORT Health Care
- ACHC Health Care
- Exchange
- CORT Nasdaq
- ACHC Nasdaq
- Market Cap
- CORT 7.1B
- ACHC 2.1B
- IPO Year
- CORT N/A
- ACHC N/A
- Fundamental
- Price
- CORT $70.84
- ACHC $25.72
- Analyst Decision
- CORT Strong Buy
- ACHC Strong Buy
- Analyst Count
- CORT 4
- ACHC 10
- Target Price
- CORT $142.00
- ACHC $52.25
- AVG Volume (30 Days)
- CORT 1.3M
- ACHC 3.6M
- Earning Date
- CORT 05-05-2025
- ACHC 05-12-2025
- Dividend Yield
- CORT N/A
- ACHC N/A
- EPS Growth
- CORT 8.36
- ACHC N/A
- EPS
- CORT 1.14
- ACHC 2.04
- Revenue
- CORT $685,446,000.00
- ACHC $3,156,417,000.00
- Revenue This Year
- CORT $35.85
- ACHC $7.90
- Revenue Next Year
- CORT $35.22
- ACHC $8.58
- P/E Ratio
- CORT $61.79
- ACHC $12.60
- Revenue Growth
- CORT 30.93
- ACHC 5.48
- 52 Week Low
- CORT $25.35
- ACHC $20.36
- 52 Week High
- CORT $117.33
- ACHC $82.41
- Technical
- Relative Strength Index (RSI)
- CORT 51.25
- ACHC 53.03
- Support Level
- CORT $69.33
- ACHC $23.83
- Resistance Level
- CORT $73.36
- ACHC $28.48
- Average True Range (ATR)
- CORT 3.36
- ACHC 1.29
- MACD
- CORT -0.23
- ACHC 0.71
- Stochastic Oscillator
- CORT 45.66
- ACHC 61.56
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.
About ACHC Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.